مباشر

IlluminaIllumina releases 2025 Corporate Responsibility Report, expanding access to genomics and accelerating global impact - PR Newswire Endpoints NewsTrumpRx adds hundreds of generic medicines to site Clinical OMICsSmart Wristband Detects Cardiac Arrest with 92% Sensitivity in Early Clinical Study Endpoints NewsAnother Paragon offshoot chooses reverse merger, this time for migraine drugs 10x Genomics BlogWhy 10x Genomics Stock Is Surging Today - TipRanks Clinical OMICsADHD Brain Marker Value in Doubt Endpoints NewsAcceleron leaders and Westlake jumpstart new IPF biotech Bio-RadAssessing Bio-Rad Laboratories (BIO) Valuation After Recent Share Price Rebound And ddPCR Growth Prospects - simplywall.st BioWorldSEC looks to reforms to Make IPOs Great Again BioWorldDaewoong nabs Innovo’s preclinical IBD asset in ₩663B deal BioWorldLife sciences ‘sweet’ opportunity in US-China talks BioWorldMedical devices evolving into intelligent, adaptive systems

Clinical OMICs ١٩ مايو ٢٠٢٦

ADHD Brain Marker Value in Doubt

Questions have been raised over decades-long links between attention-related issues and the pace at which the brain's cortex changes during childhood and adoles...

Questions have been raised over decades-long links between attention-related issues and the pace at which the brain's cortex changes during childhood and adolescence. The post ADHD Brain Marker Value in Doubt appeared first on Inside Precision Medicine .